2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with Experimental Hepatoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Z | 1 |
Wang, M | 1 |
Carr, BI | 1 |
1 other study available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Experimental Hepatoma
Article | Year |
---|---|
Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; cdc25 Phosphatases; Cell Proliferation; Cel | 2005 |